Pathobiology of lipopolysaccharide

Journal of Toxicology and Environmental Health

Volumn 51, Issue 5, 1997, Pages 415-435

  Mayeux, Philip R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; HEMOLYSIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; LIPID A; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

BACTERIAL INFECTION; CLINICAL FEATURE; ENDOTHELIUM CELL; ENDOTOXEMIA; HOST RESISTANCE; HUMAN; HYPOTENSION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SEPTICEMIA; SIGNAL TRANSDUCTION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; BACTEREMIA; CARRIER PROTEINS; ENDOTOXEMIA; ESCHERICHIA COLI; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0030839255     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984109708984034     Document Type: Article

References (116)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:865-874.
2. Ashkenazi, A., Marsters, S. A., Capon, D. J., Chamow, S. M., Figari, I. S., Pennica, D., Coeddel, D. V., Palladino, M. A. and Smith, D. H. 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA 88:10535-10539.
3. Barber, S. A., Detore, C., McNally, R. and Vogel, S. N. 1996. Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages. Infect. Immun. 64:3397-3400.
4. Bellezzo, J. M., Britton, R. S. and Fox, E. S. 1996. LPS-mediated NF kappa B activation in rat Kupffer cells can be induced independently of CD14. Am. J. Physiol. 270:C956-C961.
5. Bokemeyer, D., Sorokin, A. and Dunn, M. J. 1996. Multiple intracellular MAP kinase signaling cascades. Kidney Int. 49:1187-1198.
6. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457469.
7. Bredt, D. S., Hwang, P. M., Clatt, C. E., Lowenstein, C., Reed, R. R. and Synder, S. H. 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-718.
8. Camussi, C., Albano, E., Tetta, C. and Bussolino, F. 1991. The molecular action of tumor necrosis factor-a Eur. J. Biochem. 202:3-14.
9. Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Bubuc, C. R., Gavin, E. W., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., Lewis, M. D., Kishi, Y., Kawata, T., Bristol, J. R., Rose, J. R., Rossignol, D. P., Kobayashi K, Hishinuma, I., Kimura, A., Asakawa, N., Katayama, K. and Yamatsu, I. 1995. E5531, a pure endotoxin antagonist of high potency. Science 268:80-83.
10. Cordle, S. R., Donald, R., Read, M. A. and Hawiger, J. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11803-11810.
11. Cunha, F. Q., Assreuy, J., Moss, D. W., Rees, D., Leal, L. M. C., Moncada, S., Carrier, M., O'Donnell, C. A. and Liew, F. Y. 1994. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: Role of TNF-a and IL-1-p. Immunology 81:211-214.
12. Dahlberg, P. S., Acton, R. D., Battafarano, R. J., Uknis, M. E., Ratz, C. A., Johnston, J. W., Haseman, J. R., Gray, B. H. and Dunn, D. L. 1996. A novel endotoxin antagonist attenuates tumor necrosis factor-a secretion. J. Surg. Res. 63:44-48.
13. Dal Nogare, A. R. 1991. Southwestern Internal Medicine Conference: Septic shock. Am. J. Med. Sci. 302:50.
14. Danner, R. L., Van Dervort, A. L., Doerfler, M. E., Stuetz, P. and Parrillo, J. E. 1990. Antiendotoxin activity of lipid A analogues: Requirements of the chemical structure. Pharm. Res. 7:260-263.
15. Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M. and Parillo, J. E. 1991. Endotoxemia in human septic shock. Chest 99:169-175.
16. Ferrero, E., Jiao, D., Tsuberi, B. Z., Tesio, L., Rong, C. W., Haziot, A. and Coyert, S. M. 1993. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:2380-2384.
17. Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H. and Benjamin, E. 1996. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N. Engl. J. Med. 334:1697-1702.
18. Frasa, H., Benaissa-Trouw, B., Tavares, L., van Kessel, K., Hustinz, W., Schellekens, J., Kraaijeveld, K. and Verhoef, J. 1996a. Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli 018K5. Antimicrob. Agents Chemother. 40:999-1004.
19. Frasa, H., Benaissa-Trouw, B., Tavares, L., van Kessel, K., Poppelier, M., Kraaijevelk, K. and Verhoef, J. 1996b. Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli 018K5 infection in mice. Infect. Immun. 64:775-781.
20. Frey, E. A., Miller, D. S., Jahr, T. C., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B. and Wright, S. D. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
21. Galanos, C., Luderitz, O., Rietschel, E. T., Westphal, O., Brade, Hi, Brade, L., Freudenberg, M., Schade, U., Imoto, M., Yoshimura, H., Kusumoto, S. and Shiba, T. 1985. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. I. Biochem. 148:1-5.
22. Gallay, P., Fleumann, D., Le Roy, D., Barras, C. and Clauser, M.-P. 1994. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc. Natl. Acad. Sci. USA 91:7922-7926.
23. Gallay, P., Heumann, D., Le Roy, D., Barras, C. and Clauser, M. P. 1993. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc. Natl. Acad. Sci. USA 90:9935-9938.
24. Geng, Y., Almqvist, M. and Hansson, C. K. 1994. cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim. Biophys. Acta 1218:421-424.
25. Giral, M., Balsa, D., Ferrando, R., Merlos, M., Garcia-Rafanell, J. and Forn, J. 1996. Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock. Br. I. Pharmacol. 118:1223-1231.
26. Goldblum, S. E., Brann, T. W., Ding, X., Pugin, J. and Tobias, P. S. 1994. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accesory molecules for LPS-induced changes in endothelial barrier function, in vitro. J. Clin. Invest. 93:692-702.
27. Griffith, O. W. and Stuehr, D. J. 1995. Nitric oxide synthases: Properties and catalytic mechanism. Annu. Rev. Physiol. 57:707-736.
28. Gross, S. S. 1995. Nitric oxide: Pathophysiological mechanisms. Annu. Rev. Physiol. 57:737-769.
29. Guarner, C., Soriano, G., Tomas, A., Bulbena, O., Novella, M. T., Balanzo, J., Vilardell, F., Mourelle, M. and Moncada, S. 1993. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 18:1139-1143.
30. Hailman, E., Vasselon, T., Kelley, M., Busse, L. A., Hu, M. C.-T., Lichenstein, H. S., Detmers, P. A. and Wright, S. D. 1996. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156:4384-4390.
31. Han, J., Lee, J.-D., Tobias, P. S. and Ulevitch, R. J. 1993. Endotoxin induces rapid protein tyrosine phosphorylation in 70273 cells expressing CD14. J. Biol. Chem. 268:25009-25014.
32. 2 and cyclooxygenase 2. Biochem. Biophys. Res. Comm. 220:681-686.
33. Haziot, A., Rong, G.-W., Silver, J. and Goyert, S. M. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500-1507.
34. Haziot, A., Ferrero, E., Kontgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L. and Goyert, S. M. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-417.
35. Hill, C. S. and Treisman, R. 1995. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80:199-211.
36. c-monomethyl-L-arginine or indomethacin. J. Pharmacol. Exp. Ther. 272:452-459.
37. Ignarro, L. J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535-560.
38. Ingalls, R. R. and Golenbock, D. T. 1995. CD11 c/CD 18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 181:1473-1479.
39. Joseph, C. K., Wright, S. D., Bornmann, W. G., Randolph, J. T., Kumar, E. R., Bittman, R., Lui, J. and Kolesnick, R. N. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269:17606-17610.
40. Juan, T. S.-C., Kelley, M. J., Johnson, D. A., Busse, L. A., Hailman, E., Wright, S. D. and Lichenstein, H. S. 1995a. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270:1382-1387.
41. Juan, T. S.-C., Hailman, E., Kelley, M. J., Busse, L. A., Davy, E., Empig, C. J., Narhi, L. O., Wright, S. D. and Lichenstein, H. S. 1995b. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270:5219-5224.
42. Juan, T. S. C., Hailman, E., Kelley, M. J., Wright, S. D. and Lichenstein, H. S. 1995c. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J. Biol. Chem. 270:17237-17242.
43. Kitamura, Y., Imaizumi, R., Kitayama, Y., Esumi, H. and Nomura, Y. 1996. Possible involvement of tyrosine kinase activation in lipopolysaccharide-induced expression of Ca^-insensitive but calmodulin-coupling nitric oxide synthase in rat glial cells. J. Neurosci. Res. 43:235-245.
44. Kleinert, Hi, Euchenhofer, C., Ihrig-Biedert, I. and Forstermann, U. 1996. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kB. J. Biol. Chem. 271:6039-6044.
45. Knowles, R. G., Merrett, M., Salter, M. and Moncada, S. 1990. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270:833-836.
46. Landmann, R., Scherer, F., Schumann, R., Link, S., Sansano, S. and Zimmerli, W. 1995. LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. J. Leukocyte Biol. 57:440-449.
47. Laubach, V. E., Shesely, E. G., Smithies, O. and Sherman, P. A. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92:10688-10692.
48. Leturcq, D. J., Moriarty, A. M., Talbott, G., Winn, R. K., Martin, T. R. and Ulevitch, R. J. 1996. Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Invest. 98:1533-1538.
49. Levin, J., Poore, T. E., Zauber, N. P. and Oser, R. S. 1970. Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria. N. Engl. J. Med. 283:1313-1316.
50. Liu, S., Adcock, I. M., Old, R. W., Barnes, P. J. and Evans, T. W. 1993. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthease mRNA. Biochem. Biophys. Res. Commun. 196:1208-1213.
51. Luheshi, H., Miller, A. J., Brouwer, S., Dascombe, M. J., Rothwell, N. J. and Hopkins, S. J. 1996. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. 270:E91-E95.
52. Luss, H., Watkins, S. C., Freeswick, P. D., Imro, A. K., Nussler, A. K., Billiar, T. R., Simmons, R. L., del Nido, P. J. and McGowan, F. X. 1995. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J. Mol. Cell. Cardiol. 27:2015-2029.
53. Marra, M. N., Wilde, C. G., Griffith, J. E., Snable, J. L. and Scott, R. W. 1990. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144:662-666.
54. Marra, M. N., Wilde, C. G., Collins, M. S., Snable, J. L., Thornton, M. B. and Scott, R. W. 1992. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J. Immunol. 148:532-537.
55. Mathison, J. C., Tobias, P. S., Wolfson, E. and Ulevitch, R. J. 1992. Plasma lipopolysaccharide (LPS)-binding protein: A key component in macrophage recognition of gram-negative LPS. J. Immunol. 149:200-206.
56. Mayeux, P. R. and Shah, S. V. 1993. Intracellular calcium mediates the cytotoxicity of lipid A in LLC-PK, cells. J. Pharmacol. Exp. Ther. 266:47-51.
57. Mohaupt, M. G., Elzie, J. L., Ahn, K. Y., Clapp, W. L., Wilcox, C. S. and Kone, B. C. 1994. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 46:653-665.
58. Moro, M. A., Russell, R. J., Cellek, S., Lozasoain, I., Su, Y., Darley-Usmar, V. M., Radomski, M. W. and Moncada, S. 1996. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA 93:1480-1485.
59. Morrison, D. C. and Cochran, C. G. 1974. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharide (endotoxins). J. Exp. Med. 140:797-811.
60. 2 integrin in vivo. J. Leukocyte Biol. 59:145-151.
61. National Center for Health Statistics. 1995. Health, United States, 1994, p. 104. Hyattsvilie, MD: Public Health Service.
62. Nick, J. A., Avdi, N. J., Gerwins, P., Johnson, G. L. and Worthen, G. S. 1996. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J. Immunol. 156:4867-4875.
63. Nishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S. P., Uematsu, M., Nerem, R. M., Alexander, R. W. and Murphy, T. J. 1992. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90:2092-2096.
64. Novogrodsky, A., Vanichkin, A., Patya, M., Gazit, A., Osherov, N. and Levitzki, A. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
65. Obayashi, T., Tamura, H., Tanaka, S., Ohki, M., Takahashi, S., Arai, M., Masuda, M. and Kawai, T. 1985. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzymes and its clinical applications. Clin. Chim. Acta 149:55-65.
66. Ohlsson, K., Bjork, P., Bergenfeldt, M., Hageman, R. and Thompson, R. C. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552.
67. Park, Y. C., Jun, C. D., Kang, H. S., Kim, H. D., Kim, H. M. and Chung, H. T. 1996. Role of intracellular calcium as a priming signal for the induction of nitric oxide synthesis in murine peritoneal macrophages. Immunology 87:296-302.
68. Pereira, B. J. G., Sundaram, S., Snodgrass, B., Hogan, P. and King, A. J. 1996. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. J. Am. Soc. Nephrol. 7:479-487.
69. Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D. and Vallance, P. 1994. Effects of nitric oxide synthase inhibitor in humans with septic shock. Cardiovascular Res. 28:34-39.
70. Pinsky, M. R., Vincent, J. L., Deviere, J., Alegre, M., Kahn, R. J. and Dupont, E. 1993. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565-575.
71. Poxton, I. R. 1995. Antibodies to lipopolysaccharide. J. Immunol. Methods 186:1-15.
72. Proksch, J. W., Traylor, L. A. and Mayeux, P. R. 1996. Effects of lipid A on calcium homeostasis in proximal tubules. J. Pharmacol. Exp. Ther. 276:555-560.
73. Prpic, V., Weiel, J. E., Somers, S. D., DiGuiseppi, J., Gonias, S. L., Pizzo, S. V., Hamilton, T. A., Herman, B. and Adams, D. O. 1987. Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5-bisphosphate in murine peritoneal macrophages. J. Immunol. 139:526-533.
74. Qureshi, N. and Takayama, K. 1982. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257:1180811815.
75. Rackow, E. C. and Astiz, M. E. 1991. Pathophysiology and treatment of septic shock. J. Am. Med. Assoc. 266:548-554.
76. Raetz, C. R. H. 1986. Molecular genetics of membrane phospholipid synthesis. Annu. Rev. Cenet. 20:253-295.
77. Raetz, C. R. H. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129-170.
78. Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S. and Wenzel, R. P. 1995. The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. J. Am. Med. Assoc. 273:117-123.
79. Read, M. A., Cordle, S. R., Veach, R. A., Carlisle, C. D. and Hawiger, J. 1993. Cell-free pool of CD14 mediates activation of transcription factor NF-kB by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA 90:9887-9891.
80. Rietschel, E. T., Kirikae, T., Schade, U. F., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U., Di Padova, J., Schreier, M. and Brade, H. 1994. Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB J 8:217-225.
81. Robertson, F. M., Offner, P. J., Ciceri, D. P., Becker, W. K. and Pruitt, B. A. 1994. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch. Surg. 129:149-156.
82. Romano, M. and Hawiger, J. 1990. Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C. J. Biol. Chem. 265:1765-1770.
83. 2+ increase in human platelets. Biochem. I. 278:75-80.
84. Sato, K., Yoo, Y. C., Jukushima, A., Saiki, I., Takahashi, T. A., Fujihara, M., Tono-oka, S. and Azuma I. 1995. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia. Infect. Immun. 63:2859-2866.
85. Schletter, J., Brade, H., Brade, L., Kruger, C., Loppnow, H., Kusumoto, S., Rietschel, E. T., Flad, H.-D. and Ulmer, A. J. 1995. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect. Immun. 63:2570-2580.
86. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S. and Ulevitch, R. J. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
87. Sessa, W. C., Harrison, J. K., Barber, C. M., Zeng, D., Durieux, M. E., D'Angelo, D. D., Lynch, K. R. and Peach, J. J. 1992. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267:15274-15276.
88. Sherman, M. P., Aeberhard, E. E., Wong, V. Z., Griscavage, J. M. and Ignarro, L. J. 1993. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 191:1301-1308.
89. Shimizu, T., Honda, Z., Nakamura, M., Bito, H. and Izumi, T. 1992. Platelet-activating factor receptor and signal transduction. Biochem. Pharmacol. 44:1001-1008.
90. Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F. and Nathan, C. F. 1991. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA 88:7773-7777.
91. Takayama, K., Qureshi, N., Mascagni, P., Nashed, M. A, Anderson, L. and Raetz, C. R. H. 1983. Fatty acyl derivatives of glucosamine 1-phosphate in Escherichia coli and their relation to lipid A. J. Biol. Chem. 258:7379-7385.
92. Tanke, T., Van De Loo, J.-W., Rhim, FI., Leventhal, P. S., Proctor, R. A. and Bertics, P. J. 1991. Bacterial lipopolysaccharide-stimulated CTPase activity in RAW 264.7 macrophage membranes. Biochem. I. 277:379-385.
93. Taylor, A. H., Heavner, C., Nedelman, M., Sherris, D., Brunt, E., Knight, D. and Chrayeb, J. 1995. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270:17934-17938.
94. Theofan, C., Horwitz, A. H., Williams, R. E., Liu, P.-S., Chan, I., Birr, C., Carroll, S. F., Meszaros, K., Parent, J. B., Kasler, H., Aberle, S., Trown, P. W. and Cazzano-Santoro, H. 1994. An animo-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J. Immunol. 152:3623-3629.
95. Thomas, L. L., Sturk, A., Buller, H. R., ten Cate, J. W., Spijker, R. E. and ten Cate, H. 1984. Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am. J. Clin. Pathol. 82:203-206.
96. Tobias, P. S., Soldau, K. and Ulevitch, R. J. 1986. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164:777-793.
97. Traylor, L. A. and Mayeux, P. R. 1997. Nitric oxide generation mediates lipid A-induced oxidant injury in renal proximal tubules. Arch. Biochem. Biophys. 338:129-135.
98. Traylor, L. A., Proksch, J. W., Beanum, V. C. and Mayeux, P. R. 1996. Nitric oxide generation by renal proximal tubules: Role of nitric oxide in the cytotoxicity of lipid A. J. Pharmacol. Êxp. Ther. 279:91-96.
99. Trump, B. F. and Berezesky, I. K. 1995. Calcium-mediated cell injury and cell death. FASEB J. 9:219-228.
100. Umans, J. C. and Levi, R. 1995. Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 57:771-790.
101. Vanichkin, A., Patya, M., Gazit, A., Levitzki, A. and Novogrodsky, A. 1996. Late administration of a lipophilic tyrosine kinase inhibitor prevents lipopolysaccharide and Escherichia coli-induced lethal toxicity. J. Infect. Dis. 173:927-933.
102. Viriyakosol, S. and Kirkland, T. N. 1996. The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor. Infect. Immun. 64:653-656.
103. Walev, I., Vollmer, P., Palmer, M., Bhakdi, S. and Rose-John, S. 1996. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 93:7882-7887.
104. Wang, Y. and Hollingsworth, R. I. 1996. An NMR spectroscopy and molecular mechanics study of the molecular basis for the supramolecular structure of lipopolysaccharide. Biochemistry 35:5647-5654.
105. Warren, H. S., Danner, R. L. and Munford, R. S. 1992. Anti-endotoxin monoclonal antibodies. N. Engl. I. Med. 326:1153-1157.
106. Weinberg, J. R., Boyle, P., Meager, A. and Guz, A. 1992. Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J. Lab. Clin. Med. 120:205-211.
107. Weinstein, S. L., Sanghera, J. S., Lemke, K., DeFranco, A. L. and Pelech, S. L. 1992. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 267:14955-14962.
108. Weinstein, S. L., June, C. H. and DeFranco, A. L. 1993. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J. Immunol. 151:3829-3838.
109. Wenzel, R. P., Pinsky, M. R., Ulevitch, R. J. and Young, L. 1996. Current understandings of sepsis. Clin. Infect. Dis. 22:407-413.
110. Wightman, P. D. and Raitz, C. R. H. 1984. The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. J. Biol. Chem. 259:10048-10052.
111. Wright, C. E., Rees, D. D. and Moncada, S. 1992. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:48-57.
112. Yang, Z., Breider, M. A., Carroll, R. C., Miller, M. S. and Bochsler, P. N. 1996. Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro. J. Leukocyte Biol. 59:241-247.
113. Yoshida, M., Akaike, T., Wada, Y., Sato, K., Ikeda, K., Ueda, S. and Maeda, H. 1994. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem. Biophys. Res. Commun. 202:923-930.
114. Yu, B. and Wright, S. D. 1996. Catalytic properties of lipopolysaccharide (LPS) binding protein: Transfer of LPS to soluble CD14. J. Biol. Chem. 271:4100-4105.
115. Zahringer, U., Lindner, B., Seydel, U., Rietschel, E. T., Naoki, H., Unger, F. M., Imoto, M., Kusumoto, S. and Shiba, T. 1985. Structure of de-O-acylated lipopolysaccharide from the Escherichia coli Re mutant strain F 515. Tetrahedron Lett. 26:6321-6324.
116. Zahringer, U., Lindner, B. and Rietschel, E. T. 1994. Molecular structure of lipid A, the endo-toxic center of bacterial lipopolysaccharide. Adv. Carbohydr. Chem. Biochem. 50:211-276.